Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001477449-24-000153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-04 | 2024-05-31 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | M - OptEx | — | +5,504 | 34.8K | +19% | — |
| D | 2024-06-04 | 2024-06-03 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | S - Sale+OE | $11.16 | -1,627 | 37.7K | -4% | -$18.2K |
| DM | 2024-06-04 | 2024-05-31 | TDOC | Turitz Andrew | EVP, Corp. DEVELOPMENT | M - OptEx | $0.00 | -5,504 | 21.7K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | M | A | 3,100 | — | 39,286 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 1,627 | $11.16 | 37,659 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 3 | Common | Common Stock | 2024-05-31 | M | A | 1,348 | — | 36,186 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-05-31 | M | A | 1,056 | — | 34,838 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Derivative | Performance Stock Units | 2024-05-31 | M | D | 1,056 | $0.00 | 7,397 | D | — · — to — | 1,056 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 1,348 | $0.00 | 4,044 | D | — · — to — | 1,348 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-05-31 | M | D | 3,100 | $0.00 | 21,702 | D | — · — to — | 3,100 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |